Rational use of eculizumab in secondary atypical hemolytic uremic syndrome

Overview of attention for article published in Frontiers in immunology, January 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 39,691 followers.

Cool

RT @Emor67: Frontiers | Rational use of eculizumab in secondary atypical hemolytic uremic syndrome https://t.co/hDtXRaEkpL

RT @Emor67: Frontiers | Rational use of eculizumab in secondary atypical hemolytic uremic syndrome https://t.co/hDtXRaEkpL

RT @Emor67: Frontiers | Rational use of eculizumab in secondary atypical hemolytic uremic syndrome https://t.co/hDtXRaEkpL

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.